Salem Radio Network News Thursday, July 7, 2022


Moderna starts trial testing Omicron-specific booster shot

(Reuters) -Moderna Inc said on Wednesday it had dosed the first participant in a mid-stage study testing a booster shot of its vaccine specifically tailored to the fast-spreading Omicron COVID-19 variant.

The company also reported data showing that neutralizing antibodies against the Omicron variant declined six months after a third booster dose of its original vaccine but remained detectable.

Moderna’s Phase 2 trial will test the Omicron-specific booster in adults aged 18 years and older.

It will study the booster in individuals who received only the two-dose primary series of Moderna’s original vaccine, mRNA-1273, and also in those who received the primary series and a booster dose of the same vaccine, the company said.

Pfizer and partner BioNTech earlier this month also started a clinical trial of their vaccine specifically designed to target the Omicron variant.

(Reporting by Amruta Khandekar; Editing by Devika Syamnath)


Editorial Cartoons

View More »

Michael Ramirez
Fri, Jul 1, 2022